Le Lézard
Classified in: Business
Subject: AWD

Travelers Selects RozieAI as Innovation Prize Winner for VentureClash


ROCKY HILL, Conn., Aug. 2, 2018 /PRNewswire-PRWeb/ -- Connecticut Innovations (CI) today announced that Travelers, one of the largest property casualty insurers with major operations in Hartford, has awarded RozieAI the $25,000 VentureClash Innovation Prize.

Managed by Connecticut Innovations, VentureClash is a $5 million global venture challenge for early-stage companies in digital health, financial technology, insurance technology and the Internet of Things.

"We are constantly evaluating new technologies that will benefit our customers, agents and employees," said Michael Klein, Executive Vice President and President of Personal Insurance at Travelers. "RozieAI's innovative natural language understanding and machine learning solutions have the potential to help us to continue building long-lasting relationships with customers. We are pleased to award RozieAI with the Innovation Prize, and we look forward to further collaboration to drive meaningful customer engagement."

RozieAI is a state-of-the-art language comprehension and context management solution that helps brands offer personalized customer care at scale.

"This week, we were able to meet and engage with so many promising companies," said Matt McCooe, CEO of Connecticut Innovations. "The Innovation Prize was a way for corporate partners like Travelers to dive deeper into the semifinalist pool and identify those that could help to resolve a potential issue for their organization."

The Innovation Prize was announced at the VentureClash semifinalist pitch event at Upward Hartford on Thursday, August 2, 2018. If RozieAI establishes a Connecticut presence, the company will be eligible for an additional $25,000 in grant funding from Connecticut Innovations.

The finals event, which will feature 10 companies, will be on Thursday, October 18, at the Yale School of Management in New Haven, Conn. For more information and to register to attend the VentureClash finals, visit http://www.ventureclash.com.

About VentureClash
Managed by Connecticut Innovations, VentureClash is Connecticut's global venture challenge focused on early-stage companies. The challenge identifies high-potential companies in digital health, fintech, insurtech and the Internet of Things that will receive investments from a $5 million investment award pool. Learn more at http://www.ventureclash.com.

About Connecticut Innovations Inc.
Connecticut Innovations (CI) is Connecticut's strategic venture capital arm and is the leading source of financing and ongoing support for innovative, growing companies. CI provides venture capital and strategic guidance for early-stage technology companies, and connections to its well-established network of partners and professionals. For more information, please visit http://www.ctinnovations.com.

 

SOURCE VentureClash


These press releases may also interest you

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") and certain officers. The class action, filed in the United States District Court for the Southern District of...

at 11:00
The Georgia Trust for Historic Preservation presented 26 awards recognizing the best of preservation in Georgia during its 47th annual Preservation Awards ceremony in Athens, Ga. Security Federal Bank in Augusta received the Marguerite Williams...

at 11:00
Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against VinFast Auto Ltd. ("VinFast" or the "Company") f/k/a Black Spade Acquisition Co., ("Black Spade") and certain officers. The class action, filed in the United States District...

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") and certain officers.  The class action, filed in the United States District Court for the Southern District of...



News published on and distributed by: